Technical
Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1 and chronic conditions...
Tammy Boggiano Ayo
Tammy Boggiano Ayo, MSc, has a bachelor of science in radiochemistry and a master of science in biotechnology from Havana University. From 2010 to 2016, Tammy was Head of the Development Department at the Center of Molecular Immunology Antyter Plant. She is currently Process Development Director at INIM, an R&D facility at the Center of Molecular Immunology. Her international career has included positions in Spain, India, and China. Her expertise is in mammalian cell culture and fermentation, medium development, purification of mAbs, and glycoproteins.
Related Articles